1-Methyl-4-phenylpyridinium (MPP+) Decreases Mitochondrial Oxidation-Reduction (REDOX) Activity and Membrane Potential (Δψm) in Rat Striatum
- 31 January 2003
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 179 (1), 103-110
- https://doi.org/10.1006/exnr.2002.8056
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activityToxicology in Vitro, 2001
- Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged miceBrain Research, 1998
- Impaired mitochondrial function, oxidative stress and altered antioxidant enzyme activities following traumatic spinal cord injuryBrain Research, 1997
- MPTP-induced deficits in motor activity: Neuroprotective effects of the spintrapping agent, ?-phenyl-tert-butyl-nitrone (PBN)Journal of Neural Transmission, 1997
- MPP+Produces Progressive Neuronal Degeneration Which Is Mediated by Oxidative StressExperimental Neurology, 1997
- Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in manJournal of Neural Transmission, 1996
- MPTP‐induced oxidative stress and neurotoxicity are age‐dependent: Evidence from measures of reactive oxygen species and striatal dopamine levelsSynapse, 1994
- 2-Deoxyglucose Enhances 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine-Induced ATP Loss in the Mouse BrainJournal of Neurochemistry, 1993
- Rapid ATP Loss Caused by 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mouse BrainJournal of Neurochemistry, 1991
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) cause rapid ATP depletion in isolated hepatocytesBiochemical and Biophysical Research Communications, 1986